---
title: Sinopep-Allsino Biopharmaceutical Co., Ltd. vs Veranova
slug_a: sinopep
slug_b: veranova
site: cdmo
review_signal_gate: closed
canonical_path: /compare/sinopep/veranova
generated_by: BioBM Editorial AI
---

# Sinopep-Allsino Biopharmaceutical Co., Ltd. vs Veranova

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Sinopep-Allsino Biopharmaceutical Co., Ltd. (sinopep) is listed for cdmo. GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.

Services: 6. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Veranova (veranova) is listed for cdmo. Global CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.

Services: 13. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (13).

Review summary: Review summary withheld until site-level review gate opens.